In just the 12 years since its establishment, the National Center for Advancing Translational Sciences has brought 44 FDA-approved drugs for rare diseases to the market — and it shows no signs of slowing down.
Portland, Ore.-based Legacy Health said it will plan to divert pregnant women in labor March 17 from its Mount Hood Medical Center to another hospital even as it faces possible sanctions from the Oregon Health Authority.
The narrative that strikes threaten patient safety is not substantiated by current evidence, researchers wrote in a March 10 analysis published in The BMJ.
The rate of maternal deaths during or shortly after pregnancy rose 40 percent in 2021, making the U.S. the most dangerous place among high-income countries to give birth, The Wall Street Journal reported March 16.
Tampa (Fla.) General Hospital’s Heart and Vascular Institute has opened a new clinic designated to house what it claims is the “first and only” limb preservation program in the region.
The FDA reviewed Pfizer’s mid-to-late stage clinical trials of Paxlovid and found “no evidence of a higher rate of symptom rebound or moderate symptom rebound.”
Quality patient outcomes cannot happen without safety as a foundation, Karla Miller, MD, Nashville, Tenn.-based HCA Healthcare’s chief patient safety officer, wrote in a March 13 blog post. The hospital operator, like many others, emphasizes patient sa…
A refreshed federal report shows the healthcare industry’s efforts to improve care quality is lagging, with only 44 percent of quality measures improving over the past two decades.